LIONVILLE, Pa. (July 19)—While West Pharmaceuticals Services Inc.´s sales rose 3 percent to $117.2 million in the second quarter from $113.6 million, net income fell 38 percent to $3.1 million from $5 million during the period a year earlier. A restructuring charge of $2.9 million was the prime reason for earnings drop. During the first six months of 2001, net income fell to $8.5 million from $10.1 million, after the $2.9 million restructuring charge. Sales rose to $233.4 million from $222.3 million. The company noted that it is focusing on developing products and technologies that enhance its line of pharmaceuticals. The firm said it expects to report improved year-over-year results in the coming quarter.
Restructuring charge cuts West´s earnings
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].